(By Silas Ofori)- As Nigerians look up to the federal government for solutions to the threatening COVID -19 affliction, the National Agency for Food and Drug Administration and Control, NAFDAC, has said that it would not conduct any clinical trial to confirm the veracity of claims of producers of COVID-19 vaccines before administering IT on Nigerians.
Global Village Extra reports the Agency’s Media consultant, Sayo Akintola, as saying that “the need to conduct a clinical trial on these vaccines were not necessary as they were approved by the World Health Organisation (WHO)”, adding that despite the vaccine not going through clinical trials it would be subjected to revalidation before administration.
His words: “Once the vaccine arrives, a sample will be taken to the lab for a test. Once its safety and efficacy are certified by NAFDAC, it will be administered on Nigerians. We don’t expect anything to be different though.
“It is just for ratification. There is nothing on drugs or vaccines you will do without the consent of WHO. It is also expected that the regulatory body in each country would do its work in tandem with the WHO standard.
“The truth is that once a vaccine is approved by the WHO, it is assumed that it has passed through some preliminary stage of the trial. It is a known fact that for the WHO to sanction a vaccine, it must have gone through a series of trial here and there”.
Recall that vaccines worth 400 billion Naira has been provided to contain the spread of COVID-19 in the country.